AKLI * Stock Overview
A digital medicine company, develops cognitive treatments through game-changing technologies.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Akili, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$7.70 |
52 Week High | US$11.94 |
52 Week Low | US$4.10 |
Beta | 1.72 |
11 Month Change | 87.80% |
3 Month Change | n/a |
1 Year Change | -59.47% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -71.59% |
Recent News & Updates
Recent updates
Shareholder Returns
AKLI * | MX Healthcare Services | MX Market | |
---|---|---|---|
7D | 87.8% | 0% | 0% |
1Y | -59.5% | 0% | 0% |
Return vs Industry: AKLI * underperformed the MX Healthcare Services industry which returned -20.2% over the past year.
Return vs Market: AKLI * underperformed the MX Market which returned -2.6% over the past year.
Price Volatility
AKLI * volatility | |
---|---|
AKLI * Average Weekly Movement | n/a |
Healthcare Services Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in MX Market | 0% |
10% least volatile stocks in MX Market | 0% |
Stable Share Price: AKLI *'s share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine AKLI *'s volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | 68 | Matt Franklin | www.akiliinteractive.com |
Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It also offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization.
Akili, Inc. Fundamentals Summary
AKLI * fundamental statistics | |
---|---|
Market cap | Mex$620.03m |
Earnings (TTM) | -Mex$885.01m |
Revenue (TTM) | Mex$35.51m |
17.5x
P/S Ratio-0.7x
P/E RatioIs AKLI * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AKLI * income statement (TTM) | |
---|---|
Revenue | US$1.95m |
Cost of Revenue | US$855.00k |
Gross Profit | US$1.09m |
Other Expenses | US$49.64m |
Earnings | -US$48.54m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.62 |
Gross Margin | 56.11% |
Net Profit Margin | -2,492.04% |
Debt/Equity Ratio | 22.5% |
How did AKLI * perform over the long term?
See historical performance and comparison